Rilzabrutinib could be effective treatment option in individuals with moderate to severe chronic spontaneous urticaria: JAMA Jacinthlyn Sylvia30 April 2025 8:15 PM ISTA new study published in the Journal of American Medical Association showed that Rilzabrutinib decreased itching and hives while preserving a positive...
FDA Approves Dupilumab as First New Targeted Therapy for Chronic Spontaneous Urticaria in Over a Decade Dr. Kamal Kant Kohli21 April 2025 9:15 PM ISTThe US Food and Drug Administration (FDA) has approved dupilumab (Dupixent) for the treatment of chronic spontaneous urticaria (CSU) in patients aged...
Sanofi, Regeneron Pharma secures USFDA approval for Dupixent for chronic spontaneous urticaria Ruchika Sharma19 April 2025 1:15 PM ISTParis: Sanofi and Regeneron Pharma have received approval from the US Food and Drug Administration (FDA) for Dupixent (dupilumab) for the...
Effective therapy for chronic spontaneous urticaria may lower mortality: Study Jacinthlyn Sylvia27 Dec 2024 10:00 PM ISTA new study published in the Journal of Allergy and Clinical Immunology showed that effective therapy for chronic spontaneous urticaria (CSU) may...
Sanofi, Regeneron Dupixent sBLA accepted for USFDA review for chronic spontaneous urticaria Ruchika Sharma17 Nov 2024 4:15 PM ISTParis: Sanofi and Regeneron has announced that the US Food and Drug Administration (FDA) has accepted for review the resubmission of the...
Study Reveals Benefits of Meditation and Gayatri Mantra in Managing Chronic Urticaria Dr. Garima Soni4 Sept 2024 1:02 PM ISTIndia: A recent prospective study published in the journal Aesthetics International has unveiled the promising effects of Gayatri Mantra chanting and ...
Positive Phase III Results Emerge for Remibrutinib in Chronic Spontaneous Urticaria Treatment Medha Baranwal25 Jun 2024 8:00 PM ISTUSA: In a significant development for patients suffering from chronic spontaneous urticaria (CSU), Novartis has released promising Phase III trial...
CDSCO Panel grants Novartis Protocol Amendment Proposal to study Remibrutinib in Chronic Spontaneous Urticaria Dr. Divya Colin21 May 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
Rilzabrutinib effective and safe against chronic spontaneous urticaria, finds study Jacinthlyn Sylvia1 March 2024 12:15 AM ISTA recent study published in the Journal of Allergy and Clinical Immunology unveiled promising results from a Phase 2 study evaluating the efficacy and...
Sanofi Dupixent gets Japenese nod for chronic spontaneous urticaria Ruchika Sharma18 Feb 2024 10:00 AM ISTParis: Sanofi has announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization...
Omalizumab better treatment option for managing chronic spontaneous urticaria during pregnancy Aditi25 Dec 2023 5:00 PM ISTTreating a pregnant patient with chronic spontaneous urticaria (CSU) can be quite challenging. According to recent findings, most CSU treatments for...
Omalizumab safely manages Chronic spontaneous urticaria during pregnancy Aditi19 Dec 2023 6:00 AM ISTTreating a pregnant patient with chronic spontaneous urticaria (CSU) can be quite challenging. According to recent findings, most CSU treatments for...
